| Purpose | AGM Date | Announcement Date |
|---|---|---|
| AGM | 27 Sep 2024 | 17 Sep 2024 |
| AGM 27/09/2024 Please find enclosed Annual Report of Panacea Biotec Ltd. for financial year 2023-24. (As Per Bse Announcement Dated on 05.09.2024) We would like to inform you that the shareholders of the Company in their 40th AGM held today i.e. Friday, September 27, 2024, inter-alia approved the appointment of M/s Suresh Surana & Associates LLP, Chartered Accountants as Statutory Auditors of the Company for a period of 5 consecutive years to hold office from the conclusion of 40th AGM till the conclusion of 45th AGM of the Company in place of retiring auditors, M/s Walker Chandiok & Co. LLP, Chartered Accountants. (As Per BSE Announcement dated on 27.09.2024) The detailed voting results along with Scrutinizers report for the AGM held on September 27, 2024 of the Company is enclosed herewith (As Per BSE Announcement dated on 28.09.2024) | ||
Such a contract symbolizes Panacea Biotec's continued commitment toward global health by contributing its share of the fight against polio, a deadly disease prevalent in many pockets of the world.
Panacea Biotec's stock has seen a 37% gain over the past six months. Panacea Biotec's stock has gained a total of 76% in the last one year.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
